Your email has been successfully added to our mailing list.

×
0 -0.00237529691211402 -0.00237529691211402 0.020190023752969 -0.0973871733966747 -0.156057007125891 -0.111638954869359 -0.132066508313539
Stock impact report

Cytori announces Japan class III medical device approval for cell therapy product; shares up 31% premarket [Seeking Alpha]

CYTORI THERAPEUTICS (CYTX) 
Last cytori therapeutics earnings: 11/14 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Cytori Therapeutics (NASDAQ: CYTX ) is up   on receiving  approval for the Celution Cell Therapy System consumable bundle in Japan as a Class III medical device. The Class III designation will allow Cytori to expand its current commercial efforts in Japan and provides a clear framework for future expanded regulatory claims and reimbursement. Furthermore, Cytori has successfully outsourced an important assembly portion of the production process for its Celution Cell Therapy consumables from San Diego, CA to Viant Medical in San Antonio, Texas. See all stocks on the move » Now read: Fate Therapeutics Addresses CAR-T Limitations At ASH 2018 » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
CYTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CYTX alerts
Opt-in for
CYTX alerts

from News Quantified
Opt-in for
CYTX alerts

from News Quantified